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Background: Without exploitation of possibly immunogenic and carcinogenic bone morphogenetic protein, we
developed simple but clinically feasible artificial bone graft using osteoconductive hyaluronate (HA) hydrogels and
bioactive MegaGen synthetic bone (MGSB).
Methods: HA hydrogels were synthesized by the crosslinking reaction between carboxyl groups of HA and amine
groups of gelatin (GEL). Then, artificial bone grafts were prepared by mixing MGSB with HA-GEL hydrogels. The
bone regeneration by the MGSB/HA-GEL hydrogel complex was assessed in the skull of New Zealand white male
rabbits in 4 and 8 weeks.
Results: HA hydrogels were synthesized by the crosslinking reaction between carboxyl groups of HA and amine
groups of gelatin (GEL). Then, artificial bone grafts were prepared by mixing MGSB with HA-GEL hydrogels. In vitro
proliferation of preosteogenic cells was enhanced with increasing molecular weight of HA. In addition, histological
analysis of dissected tissues with hematoxylin and eosin staining confirmed the effective in vivo bone regeneration
by the MGSB/HA-GEL hydrogel complex. The MGSB/HA-GEL hydrogels were well resorbed and partially substituted
to the lamellar bone after implantation for 8 weeks.
Conclusions: The novel artificial bone graft of MGSB/HA-GEL hydrogel complex for effective bone regeneration
might be clinically feasible for further development.
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The repair of a bone fracture is a spontaneous, prolifera-
tive, and physiological process where the woven bone is
formed, subsequently replaced to lamellar bone, and
finally remodeled into compact bone [1-4]. However, the
bone regeneration is not easy for the cases of severe dis-
eases or large orthopedic defects [5,6]. In order for that,
artificial bone grafts can be crucial for quick and stable
ossification of the broken tissue [7]. A great variety of
attempts have been made to develop bone filler mate-
rials for the effective bone regeneration using allografts,
synthetic or natural polymers, and bioceramics [8]. In
particular, ceramic based bone grafts have been regarded
as one of the most successfully commercialized and
widely prevalent biomaterials including Bio-Oss® made* Correspondence: skhanb@postech.ac.kr
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unless otherwise stated.of the inorganic portion of bovine bone, hydroxyapatite-
based bone graft of Pro-Osteon™, synthetic biphasic cal-
cium phosphate of MBCP™, and bioactive Bone Plus™ of
MegaGen synthetic bone (MGSB) [2]. Despite the wide
applications of bone grafts, poor osteoconduction and
slow bioresorption in the initial intramembranous ossifica-
tion made discrete and precarious boundaries at the newly
formed bone tissue [9].
On account of these clinical issues, there have been
plenty of attempts to utilize growth factors like recom-
binant human bone morphogenetic protein (rhBMP), or
mesenchymal stem cells (MSC) with bone grafts [10,11].
However, these methods are complicated, possibly causing
safety issues of immune reaction, and expensive for
further clinical applications. Instead of these systems,
we tried to develop a novel hybrid bone graft consisted
with bioactive calcium phosphate synthetic bone of MGSB
and natural biopolymers of hyaluronate (HA) and gelatine
(GEL). HA is a biodegradable, biocompatible, non-td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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body. In addition, HA is known to be angiogenic and
osteoconductive, contributing to the effective bone tissue
regeration [11-13]. According to the most recent reports,
it was demonstrated that MSCs are migrated, granulated,
and differentiated to the osteoblastic cells in the presence
of the low molecular weight HA [14]. In addition, small
fragments of HA with several repeating units can promote
angiogenesis significantly [15,16], which is necessary for
replacing the fragile woven bone to the sustainable lamel-
lar bone [4].
In this work, we prepared a novel bone graft complex
of MGSB and HA-GEL hydrogel. HA-GEL hydrogels
were synthesized and compared with HA-divinyl sulfone
(HA-DVS) hydrogels in terms of degradation kinetics.
HA hydrogels were thought to continuously provide low
molecular weight HA fragments by the degradation in
the body, serving as a perfect way to facilitate and advance
the early ossification and the sequential bone regeneration.
The hydrolysed collagen of GEL was used as a crosslinker
due to the hemostatic properties [17]. Meanwhile, the
effect of the molecular weight of HA was investigated on
the proliferation of preosteogenic cells of MC3T3 on the
bioactive MGSB. After implantation of four different
samples of a control, MGSB, MGSB/HA, and MGSB/HA-
GEL hydrogel to the calvarial critical sized bone defects in
the skull of New Zealand white male rabbits, the bone
regeneration was assessed by histological analysis with
hematoxylin and eosin (H&E) staining in 4 and 8 weeks.
Methods
Materials
Sodium hyaluronate (HA), sodium salt of hyaluronic
acid (234 kDa), was purchased from Lifecore (Chaska,
MN). Gelatin (GEL) was purchased from Yakuri Pure
Chemicals(Kyoto, Japan). Phosphate buffered saline
(PBS) tablet, H&E, glutathione, and hyaluronidase from
Streptomyces hyalurolyticus were purchased from Sigma-
Aldrich (St. Louis, MO). 1-Ethyl-3-[3-(dimethylamino)
propyl] carbodiimide (EDC), divinyl sulfone (DVS) were
purchased from Tokyo Chemical Industry (Tokyo, Japan).
Hydrochloric acid and sodium hydroxide were obtained
from Wako Pure Chemical Industries (Osaka, Japan). All
the chemicals were used without further purification.
Synthesis of hydrogels
HA-DVS hydrogels were synthesized as we previously
reported elsewhere [18]. HA (100 mg) was dissolved in
0.2 N sodium hydroxide (2.5 ml) and DVS (26.47 μl) was
added to the HA solution. After the Michael addition
reaction between hydroxyl groups of HA and double
bonds of DVS for 1 h, the HA-DVS hydrogels were
sealed within prewashed dialysis membrane (MWCO of
7 kDa) and dialyzed against PBS for 24. HA-GELhydrogels were prepared by carbodiimide reaction be-
tween carboxyl groups of HA and amine groups of GEL.
HA (100 mg) and GEL (72.5 mg) were dissolved in DI
water (1.25 ml), respectively, and the two solutions were
mixed for 6 h. Then, EDC (191.7 mg) and sulfo-NHS
(54.1 mg) were added for the crosslinking reaction over-
night. The HA-GEL hydrogels were sealed within pre-
washed dialysis membrane (MWCO of 7 kDa) and
dialyzed against PBS for 72 h.
In vitro hydrogel degradation test
Two kinds of HA hydrogel samples described above
were prepared in syringes for in vitro degradation tests.
Each of HA-DVS hydrogel and HA-GEL hydrogel was
put into a vial, respectively. Then, sodium phosphate
buffer (0.2 M, pH = 6.2) containing 40 U of hyaluroni-
dase was added to the vials. The samples were incubated
at 37°C for the predetermined times (0–36 h). After that,
the supernatant was completely removed and the
remaining weight of HA hydrogels was measured with a
balance. The degree of HA hydrogel degradation was
represented by the weight ratio (%) of the remaining hy-
drogel to the original hydrogel. Triplicates were carried
out for each sample.
In vitro cell proliferation assay
MC3T3-E1 cells were seeded into 24 well cell culture
plate at an initial density of 5 × 103 cells per well with
200 mg of artificial bone graft (MGSB), which were in-
cubated at 37°C in cell culture media (α-MEM, 10% FBS,
1× antibiotics). After incubation for 7 days, the spherical
bone grafts were fixed with 4% paraformaldehyde and
washed several times, and serially dehydrated to 100%
ethanol. Then, the cells on MGSBs were observed by
scanning electron microscopy (SEM, Philips electron op-
tics) after gold coating. The proliferation of MC3T3 cells
was assessed by MTT assay at the predetermined times
(3, 5, and 7 days).
In vivo implantation and histological analysis
Three New Zealand white male rabbits weighing about 4
kg were used per each experimental group. They were
anesthetized by intramuscular injection of zoletil and
rompun (v/v = 1/1, 0.1 cc/kg). Two critical sized bone
defects of each New Zealand White male rabbit with a
diameter of 9 mm were made as we described elsewhere
[18]. HA-GEL hydrogels were completely homogenized
to micro-sized hydrogels with a homogenizer (T-18
basic; IKA, Tokyo, Japan) at 8000 rpm for 5 min and
mixed with MGSB (40 mg of MGSB and 100 μl of
microhydrogel), which were inserted into the calvarial
critical-sized bone defects. For comparison, the bone de-
fects were also filled with MGSB, MGSB/HA, or
remained without graft as a nongrafted control. The
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phometric analyses after H&E staining (n = 3 for each
sample) in 4 and 8 weeks. The regenerated bone defect
samples were fixed with 10% formalin for 2 days and
decalcified with 10% ethylenediaminetetraacetic acid for
2–3 weeks. The degree of bone regeneration was assessed
by observation with a digital camera-connected light
microscope (Olympus, Tokyo, Japan). We complied with
the POSTECH institutional ethical protocols for animals.
Results and discussion
To take advantages of osteoconductive HA, we developed
an artificial hybrid bone graft of MGSB and HA-GEL
hydrogels for bone tissue engineering applications. HA
hydrogels were designed to provide HA fragments con-
tinuously for effective bone regeneration. As schematically
shown in Figure 1, we prepared HA microhydrogels
mixed with synthetic bone graft of MGSB. Two types of
HA hydrogels were prepared by the crosslinking with
DVS and GEL for comparison. HA-DVS hydrogels were
synthesized by the Michael addition reaction between
double bond of DVS and hydroxyl group of HA in a basic
solution (Figure 1B). HA-GEL hydrogels were synthesized
by simple EDC chemistry between carboxyl groups of HA
and amine groups of GEL (Figure 1C).(A)
Figure 1 Schematic representation of (A) artificial bone graft compos
of (B) HA-DVS and (C) HA-GEL hydrogels.Figure 2 shows the SEM image of MC3T3-E1 cells
cultured on the artificial bone graft of MGSB, reflecting
the biocompatibility of MGSB. The preosteoblast was
well attached and proliferated to the surface of micro-
porous bone grafts (Figure 2). Then, we investigated the
effect of HA on the proliferation of MC3T3-E1 cells on
MGSB. Interestingly, the cell proliferation was higher in
the presence of HA with a molecular weight of 100 kDa
than 6.4 kDa (Figure 3). The results were well matched
with other reports on the effect of HA molecular weight
on in vitro cell viability and cell proliferation [11,19].
The more effective bone regeneration in the case of high
molecular weight HA might be ascribed to the relatively
long-term delivery of the small fragments of HA, corro-
borating the rationale of the artificial hybrid bone graft
of MGSB and HA hydrogels.
Low molecular weight HA is known to play an import-
ant role in bone regeneration, promoting the differenti-
ation [11,20], vascularization [15,16], and migration [4,14]
of MSCs. In this respect, we designed a fast degradable
HA hydrogel to supply small fragment of HA for the early
time of bone regeneration. We compared the degradation
of HA-GEL hydrogel with HA-DVS hydrogel after treat-
ment with hyaluronidase. HA-GEL hydrogels with a lower
crosslinking density were degraded faster than HA-DVS(B)
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Figure 2 Scanning electron microscopic image of MC3T3-E1 cells proliferated on the surface of MGSB after gold coating.
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http://www.biomaterialsres.com/content/18/1/8hydrogels (Figure 4). In addition, GEL might be more
vulnerable than DVS during the hyaluronidase treatment
[21]. Especially, the degradation of HA-GEL hydrogel can
be enhanced in the body due to the GEL degrading
enzymes such as matrix metalloproteases (MMP).
HA-DVS hydrogels with remaining carboxyl groups
swelled more than HA-GEL hydrogels [21]. The relatively
slow degradation and high swelling of HA-DVS hydrogels
might not be advantageous for bone regeneration, inhibit-
ing the attachment and proliferation of osteoblast cells
in vivo [18].
The calvarial critical sized bone defects were formed
in the New Zealand white rabbits to assess the effect of
PBS, MGSB only, MGSB/HA solution, and MGSB/HA-
GEL hydrogel on the bone regeneration (Figure 5). We
could confirm the effective bone regeneration by the
osteoconductive HA (Figure 5B and C). The regeneratedMw of Hyaluronic Acid (HA)
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Figure 3 Effect of the molecular weight of HA on the proliferation
of MC3T3-E1 cells.bone by MGSB/HA was well matured around the MGSB,
whereas that by MGSB only was partially segregated.
Figure 5D shows the more effective bone regeneration by
MGSB/HA-GEL hydrogels than those by the control sam-
ples. The newly formed bone was well interconnected to
the MGSB after bone regeneration for 4 weeks. Remark-
ably, as shown in Figure 5E, MGSB was partially degraded
and substituted to the lamellar bone structure after bone
regeneration for 8 weeks. It was thought that osteoblast
and MSC were recruited and proliferated at the initial
bone regeneration, followed by the sequential replacement
with the lamellar bone.
More than half century, various bone grafts such as
hydroxyapatite [10], tricalcium phosphate [10], bioactive
glass [22], and poly(methylmethacrylate) [23] have been
developed for bone tissue engineering applications. Des-
pite the wide clinical applications, these bone grafts wereFigure 4 In vitro degradation of HA-DVS and HA-GEL hydrogels
in the presence of hyaluronidase.
(A)
(C)
(D)
(E)
(B)
Figure 5 Photomicrographs if the calvarial critical-sized bone defects in New Zealand white rabbits after bone regeneration for
4 weeks: (A) No treatment, (B) MGSB only, (C) MGSB/HA, and (D) MGSB/HA-GEL hydrogel. (E) MGSB/HA-GEL hydrogel after bone
regeneration for 8 weeks. Scale bars: left, 1000 μm; right, 200 μm.
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http://www.biomaterialsres.com/content/18/1/8not sufficient for the effective bone regeneration. Conclu-
sively, HA-GEL hydrogels mixed with MGSB might im-
prove the formation of the initial callus by providing
osteoconductive HA fragments with increasing degrad-
ation in the body for the effective bone regeneration. HA
and GEL have been widely used as a bone scaffold enhan-
cing cell proliferation and modulating bone differentiation
[11]. Although BMPs enable accelerated bone regener-
ation, this approach is not clinically feasible because they
are immunogenic and cause a cancer in some cases. In
contrast, the simple hybrid bone graft of MGSB and HA-
GEL hydrogels resulted in effective bone regeneration,
reflecting the feasibility for further clinical applications.Conclusions
We successfully developed an artificial bone graft com-
posed of MGSB and HA hydrogels crosslinked with gel-
atin. The HA-GEL hydrogel was prepared to supply HA
continuously during the bone regeneration. The MGSB/
HA-GEL hydrogels resulted in the effective bone regen-
eration after implantation to the critical-sized calvarial
bone defect in the skull of New Zealand white rabbits
for 4 weeks. The MGSB in the complex was remodeled
to the new bone by the homeostasis of mature bone,
namely osteogenesis and osteoclasis in 8 weeks. The novel
MGSB/HA-GEL hydrogel complex might be feasible for
further clinical applications.
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